Sleep Apnea Threatens Women’s Cognitive Health | Ignored and Undiagnosed
Alzheimer’s disease affects more than 6 million Americans, and emerging research identifies Obstructive Sleep Apnea (OSA) as a significant, modifiable risk factor. Interrupted breathing during sleep can impair memory and accelerate cognitive decline, with growing evidence linking poor sleep to an increased risk of dementia. In response, Vivos Therapeutics is offering innovative, airway-centered treatments aimed at improving sleep quality and supporting long-term brain health.
Cooler Heads Secures Series A Funding to Revolutionize Scalp Cooling Technology for Chemotherapy Patients
By cooling the scalp before, during, and after chemotherapy, Amma™ reduces blood flow to hair follicles, shielding them from chemotherapy drugs and therefore preventing hair loss. Amma™ offers a continuous cooling system that eliminates the need for dry ice or frequent cap changes, making it a more accessible alternative to traditional methods.
DualityBio Reports: Next-Generation HER3 ADC DB-1310 Granted FDA Fast Track Designation
This designation is for the treatment of adult patients with advanced, unresectable or metastatic nonsquamous non-small cell lung cancer (nsqNSCLC) with an EGFR exon 19 deletion or L858R mutation with disease progression on or after treatment with a third-generation EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy.
Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025
Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation for continued care.
Presentations on tau to explore its biological role, the development of targeted therapies and biomarkers, and the future integration of these innovations into clinical practice.
Movora Becomes Exclusive Distributor of Aesculap Surgical Power Systems in North America
Guy Spörri, CEO of Movora said, “This agreement represents a significant step forward in our mission to support veterinary professionals with world-class surgical technologies.”
HNL Lab Medicine Opens New Location at Tower Place in Bethlehem
Leanne Anderson, Marketing Director at HNL Lab Medicine: “It’s important to us that children feel safe and parents feel supported. This new location is one more way we’re helping families get the care they need, close to home.”
Unlocking People Potential: The Power of Data to Drive Smarter HR Outcomes and Future Workforce Strategies
What Is Data-Driven HR? Traditionally, many HR decisions were based on intuition, legacy processes, or subjective feedback. However, the emergence of data-driven human resources turns this approach on its head by prioritizing analytics, quantitative insights, and evidence-based strategies. This powerful shift helps organizations move beyond guesswork, ensuring every people initiative is aligned with strategic business […]
Champions Oncology Announces Appointment of New CEO
Effective August 25, 2025.
Medical Device Studies Regulatory Requirements and Adverse Event Reporting Training Course | Understanding MDR – Essential Course on New Regulations and PSURs
ONLINE EVENT: September 15-16, 2025 – Research and Markets
Phase 3 Study of MR-139 for Blepharitis Update Provided by Viatris
The MR-139 3001 Phase 3 trial consisted of a randomized, placebo-controlled, double-masked prospective study, with a total of 477 patients who were randomized to receive either MR-139 or placebo, self-administered to the eyelids twice daily, treated and observed over 12 weeks.
Healthcare Dispensing Systems Market worth $6.27 billion by 2030 with 6.3% CAGR
Explore the Healthcare Dispensing Systems Market growth, projected to hit $6.27 billion by 2030 with a 6.3% CAGR according to MarketsandMarkets.
Dr Richard J Friedman Appointed CMO at Exactech
Experienced surgeon to provide cross-functional guidance as company focuses on future growth and innovation.